Skip to content
The Nexus
DossierENTITY

Maryland Prescription Drug Affordability Board

Coverage of Maryland Prescription Drug Affordability Board in the Nexus archive.

Earliest in view: May 18 · 22:08 UTCMost recent: May 18 · 22:08 UTC
Co-mentioned in this coverage
Ozempictopic1Medicareorganization1Andrew Yorkperson1Marylandplace1
Recent coverage
  • HEALTHMay 18 · 22:08 UTCSTAT NEWS
    STAT+: Maryland state affordability board places a price cap on Ozempic

    The Maryland Prescription Drug Affordability Board set a price cap on Ozempic, a diabetes treatment, at $274 for a 30-day supply, expected to save $5.8 million a year. The board aims to lower the cost of the medicine for state and local governments by January 2027. This move is part of the board's efforts to regulate high-cost drugs in Maryland.